Credits Earned (2024) Crédits obtenus

Redeem Prepaid Membership

Tools for Practice Outils pour la pratique

#28 Are Acetaminophen and Ibuprofen Equivalent in the Treatment of Paediatric Fever?

If we provide a recommendation regarding the treatment of paediatric fever, is acetaminophen or ibuprofen superior?

Treatment of pediatric fever is debated and should be discussed with parents/patients.  If clinicians are going to recommend a treatment, ibuprofen offers superior fever reduction with no increase in adverse events.  

CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session

A meta-analysis and two randomized controlled trials (RCT) provide some guidance. 
  • Review of Ibuprofen versus Acetaminophen:1 
    • 10 trials, 1,078 patients. 
    • Dose: Ibuprofen 5-10 mg/kg and acetaminophen 10-15mg/kg. 
    • Outcome:  
      • Ibuprofen statistically superior at 2, 4 and 6 hours. 
      • At 4-6 hours approximately 15% more ibuprofen patients will have fever reduction [number needed to treat (NNT) 7]. 
    • Similar results in pooled analysis of 2 RCTs of children 6 months to 11 years (319 patients) of single dose ibuprofen versus acetaminophen.2    
  • PITCH:3 RCT (156 children age six months to six years) comparing ibuprofen 10mg/kg q6-8 hours, acetaminophen 15mg/kg q4-6 hours or both. 
    • Outcomes (statistically significant): 
      • Time without fever in first four hours: Combination superior to acetaminophen by 55. 3 minutes but not ibuprofen.   
      • Combination had reduced fever time in first 24 hours. 
        • Acetaminophen 4.4 hours more. 
        • Ibuprofen 2.5 hours more. 
      • Authors recommended ibuprofen due to superiority to acetaminophen, similar to combination with less risk of excess dosing. 
    • Cochrane4 review of PITCH plus 5 other studies found similar. 
  • Overdosing of medications reported in 21% children in PITCH.3   
  • Debate:  
    • No evidence that fever itself is harmful.5 
    • Antipyretics not shown to prevent febrile seizures.6,7  
    • No evidence that treating fever in mild infections is harmful (unless overdosed) and present evidence shows it does not prolong illness.8 
    • If treated, goal should likely be comfort (although no studies have investigated “comfort” in fever). 
  • Adverse effects of ibuprofen compared to acetaminophen: 
    • Asthma: Ibuprofen carries the same or perhaps slightly lower risk versus acetaminophen9  
    • Reye Syndrome: No increased risk.10,11 
    • GI Effect & Renal: No evidence of risk.12 Canadian Pediatric Society advises against ibuprofen if a child is not “drinking reasonably well.”13 
    • “Systemic” Reaction: No evidence of risk.12 
updated dec 16 2017 by Ricky

Latest Tools for Practice
Derniers outils pour la pratique

#367 Oral Calcitonin Gene-related Peptide Antagonists: A painfully long name for the acute treatment of migraines

What are the risks and benefits of ubrogepant for the acute treatment of episodic migraines?
Read Lire 0.25 credits available Crédits disponibles

#366 Looking for Closure: Managing simple excisions or wounds efficiently

What are some options for efficiency in wound closure?
Read Lire 0.25 credits available Crédits disponibles

#365 Shrooms for Glooms: Evidence for psilocybin for depression

What are the benefits and harms of psilocybin for treatment-resistant/recurrent depression?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session

  • G. Michael Allan MD CCFP
  • Yvonne Shevchuk BSP PharmD

1. Perrott DA, Piira T, Goodenough B, et al. Arch Pediatr Adolesc Med. 2004; 158:521-6.

2. Jayawardena S, Kellstein D. Clin Pediatr. 2017; 56:1120-7.

3. Hay AD, Costelloe C, Redmond NM, et al. BMJ. 2008; 337:a13021

4. Wong T, Stang AS, Ganshorn H, et al. Cochrane Database Syst Rev 2013; 10:CD009572.

5. Mackowiak PA. Clin Infect Dis. 2000; 31(Suppl5):S185-9.

6. Duffner PK, Baumann RJ, Berman P, et al. Pediatrics. 2008; 121:1281-6.

7. Offringa M, Newton R, Cozijnsen MA, Nevitt SJ. Cochrane Database System Rev 2017; 2:CD003031

8. Purssell E, While AE. J Pediatr. 2013 Sep; 163(3):822-827.e1-2.

9. Kanabar D, Dale S, Rawat M. Clin Ther. 2007;29:2716–2723.

10. Southey ER, Soares-Weiser K, Kleijnen J. Curr Med Res Opin. 2009; 25(9):2207-22.

11. Lesko SM, Mitchell AA. Pediatrics. 1999; 104(4):e39.

12. Lesko SM, Mitchell AA. JAMA. 1995; 273(12):929-33.

13. Canadian Pediatric Society. Available at: Last Accessed: October 24, 2013.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.

Most recent review: 16/12/2017

By: Ricky D Turgeon BSc(Pharm), ACPR, PharmD


Evidence Updated: Cochrane review & 2 RCTs added; Bottom Line: Unchanged.

Learning at a glance
Yearly credits
Acquired ()
Your content by topic
Cardiology Dermatology Emergency
My Bookmarks